91 related articles for article (PubMed ID: 27108762)
1. Treatment patterns in patients with advanced gastric cancer in Taiwan.
Cuyun Carter G; Kaltenboeck A; Ivanova J; Liepa AM; San Roman A; Koh M; Rajan N; Cheng R; Birnbaum H; Chen JS
Asia Pac J Clin Oncol; 2017 Jun; 13(3):185-194. PubMed ID: 27108762
[TBL] [Abstract][Full Text] [Related]
2. Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea.
Carter GC; Kaltenboeck A; Ivanova J; Liepa AM; San Roman A; Koh M; Rajan N; Cheng R; Birnbaum HG; Kim JS; Bang YJ
Cancer Res Treat; 2017 Jul; 49(3):578-587. PubMed ID: 27618820
[TBL] [Abstract][Full Text] [Related]
3. Treatment Patterns Among Patients with Metastatic and/or Unresectable Gastric Cancer in Brazil.
de Alencar Camara Vieira FM; de Souza Victorino APO; de Iracema Gomes Cubero D; Beato CAM; Minowa E; Julian GS; Novick D
J Gastrointest Cancer; 2019 Dec; 50(4):780-793. PubMed ID: 30078125
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of patients with advanced or metastatic gastric cancer in Colombia.
Novick D; Leonardi F; Lee Kay Pen D; Montoya-Restrepo ME; Avendaño C; Siddi S; Moneta MV; Haro JM; Velasquez JC
J Med Econ; 2019 Sep; 22(9):891-900. PubMed ID: 31066594
[No Abstract] [Full Text] [Related]
5. Real-world treatment patterns among patients with advanced gastric cancer in Russia: a chart review study.
Tjulandin SA; Tryakin AA; Besova NS; Sholokhova E; Ivanova JI; Cheng WY; Schmerold LM; Thompson-Leduc P; Novick D
J Drug Assess; 2019; 8(1):150-158. PubMed ID: 31656688
[No Abstract] [Full Text] [Related]
6. Efficacy of a triplet and doublet-based chemotherapy as first-line therapy in patients with HER2-negative metastatic gastric cancer: a retrospective analysis from the clinical practice.
Laterza MM; Pompella L; Petrillo A; Tirino G; Pappalardo A; Orditura M; Troiani T; Ciardiello F; Di Martino N; De Vita F
Med Oncol; 2017 Oct; 34(11):186. PubMed ID: 29043514
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of patients with locally advanced or metastatic gastric cancer in Argentina.
Novick D; Mendez G; Carballido M; Rizzo M; O'Connor JM; Castillo J; Lee Kay Pen D; Siddi S; Rodante D; Moneta MV; Haro JM
Medwave; 2019 Sep; 19(8):e7692. PubMed ID: 31596840
[TBL] [Abstract][Full Text] [Related]
8. Irinotecan as the key chemotherapeutic agent in second-line treatment of metastatic gastric cancer after failure of first-line S-1 or S-1/CDDP therapy.
Goto A; Sukawa Y; Igarashi H; Onodera K; Aoki Y; Suzuki K; Yonezawa K; Yawata A; Kobayashi T; Kaneto H; Shimizu H; Wakasugi H; Matsunaga Y; Itoh M; Okuda H; Arimura Y; Shinomura Y
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1461-6. PubMed ID: 21945893
[TBL] [Abstract][Full Text] [Related]
9. Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone.
Kang JH; Lee SI; Lim DH; Park KW; Oh SY; Kwon HC; Hwang IG; Lee SC; Nam E; Shin DB; Lee J; Park JO; Park YS; Lim HY; Kang WK; Park SH
J Clin Oncol; 2012 May; 30(13):1513-8. PubMed ID: 22412140
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Sequential Ipilimumab Monotherapy versus Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer.
Bang YJ; Cho JY; Kim YH; Kim JW; Di Bartolomeo M; Ajani JA; Yamaguchi K; Balogh A; Sanchez T; Moehler M
Clin Cancer Res; 2017 Oct; 23(19):5671-5678. PubMed ID: 28655793
[No Abstract] [Full Text] [Related]
11. Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer--a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
Thuss-Patience PC; Kretzschmar A; Bichev D; Deist T; Hinke A; Breithaupt K; Dogan Y; Gebauer B; Schumacher G; Reichardt P
Eur J Cancer; 2011 Oct; 47(15):2306-14. PubMed ID: 21742485
[TBL] [Abstract][Full Text] [Related]
12. Population-based outcomes research on treatment patterns and impact of chemotherapy in older patients with metastatic gastric cancer.
Lee KW; Lee JH; Kim JW; Kim JW; Ahn S; Kim JH
J Cancer Res Clin Oncol; 2016 Mar; 142(3):687-97. PubMed ID: 26567125
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
Fanotto V; Uccello M; Pecora I; Rimassa L; Leone F; Rosati G; Santini D; Giampieri R; Di Donato S; Tomasello G; Silvestris N; Pietrantonio F; Battaglin F; Avallone A; Scartozzi M; Lutrino ES; Melisi D; Antonuzzo L; Pellegrino A; Ferrari L; Bordonaro R; Vivaldi C; Gerratana L; Bozzarelli S; Filippi R; Bilancia D; Russano M; Aprile G
Oncologist; 2017 Dec; 22(12):1463-1469. PubMed ID: 28860412
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.
Fanotto V; Cordio S; Pasquini G; Fontanella C; Rimassa L; Leone F; Rosati G; Santini D; Giampieri R; Di Donato S; Tomasello G; Silvestris N; Pietrantonio F; Battaglin F; Avallone A; Scartozzi M; Lutrino ES; Melisi D; Antonuzzo L; Pellegrino A; Torri V; Aprile G
Gastric Cancer; 2017 Sep; 20(5):825-833. PubMed ID: 28028664
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of irinotecan in combination with cisplatin as second-line chemotherapy in patients with metastatic or locally advanced gastric cancer.
Shen WC; Yang TS; Hsu HC; Chen JS
Chang Gung Med J; 2011; 34(6):590-8. PubMed ID: 22196061
[TBL] [Abstract][Full Text] [Related]
16. Predictors of heterogeneity in the first-line treatment of patients with advanced/metastatic gastric cancer in the U.S.
Abrams T; Hess LM; Zhu YE; Schelman W; Liepa AM; Fuchs C
Gastric Cancer; 2018 Sep; 21(5):738-744. PubMed ID: 29392573
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of fibroblast growth factor receptor 2 gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers.
Seo S; Park SJ; Ryu MH; Park SR; Ryoo BY; Park YS; Na YS; Lee CW; Lee JK; Kang YK
Oncotarget; 2017 May; 8(20):33844-33854. PubMed ID: 27802183
[TBL] [Abstract][Full Text] [Related]
18. An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices.
Ma E; Bonthapally V; Chawla A; Lefebvre P; Swords R; Lafeuille MH; Fortier J; Emond B; Duh MS; Dezube BJ
Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):625-636.e3. PubMed ID: 27686689
[TBL] [Abstract][Full Text] [Related]
19. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel monotherapy as a second-line treatment after failure of fluoropyrimidine and platinum in advanced gastric cancer: experience of 154 patients with prognostic factor analysis.
Jo JC; Lee JL; Ryu MH; Sym SJ; Lee SS; Chang HM; Kim TW; Lee JS; Kang YK
Jpn J Clin Oncol; 2007 Dec; 37(12):936-41. PubMed ID: 18211985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
